As of today, Abbott Laboratories last 12-month Revenue is $40.7B , EBITDA is $8.4B and Net Income is $5.6B , based on the financial report for Jun 30, 2024 (Q2 2024).
As of today, Abbott Laboratories Total Assets are $73.0B and Total Liabilities are $33.5B , based on the financial report for Jun 30, 2024 (Q2 2024).
As of today, Abbott Laboratories last 12-month Cash Flow from Operating Activities is $1,960.0M, Cash Flow from Investing Activities is ($453.0M) and Cash Flow from Financing Activities is ($791.0M), based on the financial report for Jun 30, 2024 (Q2 2024).
As of today, Abbott Laboratories last 12-month Free Cash Flow is $5,654.0M , based on the financial report for Jun 30, 2024 (Q2 2024).